SEC Form 4 · accession 0001179110-16-029559
OSIRIS THERAPEUTICS, INC. · OSIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Dresner
Officer — Interim President & CEO
Period of report
Sep 12, 2016
Accepted (ET)
Sep 12, 2016 · 4:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360886
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (right to buy)F1 | $5.30 | Sep 12, 2016 | A | 5,000 | A | Sep 12, 2016 | Dec 31, 2017 | Non-Qualified Stock Option (right to buy) | 5,000 | 20,000 | D |
Explanation of responses
- F1Options to purchase 5,000 shares of the common stock of the Registrant shall become exercisable immediately with respect to the underlying shares.